Skip to main content
icon for Casos de sarampo nos EUA até 31 de agosto?

Casos de sarampo nos EUA até 31 de agosto?

icon for Casos de sarampo nos EUA até 31 de agosto?

Casos de sarampo nos EUA até 31 de agosto?

NOVO
31 ago 2026
Polymarket

$8,401 Vol.

Polymarket

2.750+

$20 Vol.

50%

2.500+

$447 Vol.

99%

2550+

$1,096 Vol.

95%

2600+

$3,603 Vol.

89%

2650+

$20 Vol.

51%

2700+

$272 Vol.

27%

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**As of August 6, 2026, the CDC has confirmed 2,465 measles cases nationwide for the year, already surpassing the full-year 2025 total of 2,289 and marking the highest annual count in over three decades.** Most cases (94%) are linked to 38 ongoing or new outbreaks across more than 40 jurisdictions, with 92% of patients unvaccinated or of unknown status and the largest clusters tied to sustained community transmission in states like Pennsylvania and Texas. Recent weekly increments of 50–94 cases reflect continued local spread rather than importations. CDC data releases, typically updated mid-week, provide the primary near-term signal for traders, as August 31 resolution hinges on whether the current pace of reporting sustains or decelerates amid summer travel patterns and vaccination outreach efforts. Historical precedent shows outbreaks can accelerate rapidly in under-vaccinated populations before containment measures take effect.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$8,401
Data de Término
31 ago 2026
Mercado Aberto
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.**As of August 6, 2026, the CDC has confirmed 2,465 measles cases nationwide for the year, already surpassing the full-year 2025 total of 2,289 and marking the highest annual count in over three decades.** Most cases (94%) are linked to 38 ongoing or new outbreaks across more than 40 jurisdictions, with 92% of patients unvaccinated or of unknown status and the largest clusters tied to sustained community transmission in states like Pennsylvania and Texas. Recent weekly increments of 50–94 cases reflect continued local spread rather than importations. CDC data releases, typically updated mid-week, provide the primary near-term signal for traders, as August 31 resolution hinges on whether the current pace of reporting sustains or decelerates amid summer travel patterns and vaccination outreach efforts. Historical precedent shows outbreaks can accelerate rapidly in under-vaccinated populations before containment measures take effect.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Volume
$8,401
Data de Término
31 ago 2026
Mercado Aberto
Jul 31, 2026, 10:25 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by August 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Cuidado com os links externos.

Frequently Asked Questions

"Casos de sarampo nos EUA até 31 de agosto?" is a prediction market on Polymarket with 8 possible outcomes where traders buy and sell shares based on what they believe will happen. The current leading outcome is "2.400+" at 100%, followed by "2450+" at 100%. Prices reflect real-time crowd-sourced probabilities. For example, a share priced at 100¢ implies that the market collectively assigns a 100% chance to that outcome. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

"Casos de sarampo nos EUA até 31 de agosto?" is a newly created market on Polymarket, launched on Jul 31, 2026. As an early market, this is your opportunity to be among the first traders to set the odds and establish the market's initial price signals. You can also bookmark this page to track volume and trading activity as the market gains traction over time.

To trade on "Casos de sarampo nos EUA até 31 de agosto?," browse the 8 available outcomes listed on this page. Each outcome displays a current price representing the market's implied probability. To take a position, select the outcome you believe is most likely, choose "Yes" to trade in favor of it or "No" to trade against it, enter your amount, and click "Trade." If your chosen outcome is correct when the market resolves, your "Yes" shares pay out $1 each. If it's incorrect, they pay out $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current frontrunner for "Casos de sarampo nos EUA até 31 de agosto?" is "2.400+" at 100%, meaning the market assigns a 100% chance to that outcome. The next closest outcome is "2450+" at 100%. These odds update in real-time as traders buy and sell shares, so they reflect the latest collective view of what's most likely to happen. Check back frequently or bookmark this page to follow how the odds shift as new information emerges.

The resolution rules for "Casos de sarampo nos EUA até 31 de agosto?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.